Gland Pharma Ltd (NSE:GLAND) reports a strong Q4 with 22% revenue growth, driven by CDMO business and US market expansion.

Even though Ascendis Pharma A/S ( NASDAQ:ASND ) posted strong earnings recently, the stock hasn't reacted in a ...

The JV aims to scale the commercialisation of branded and specialised pharmaceutical products for the US market.

Gland Pharma Ltd reported a 96.6% year-on-year jump in Q4 net profit to ₹366.6 crore, supported by 22.3% revenue growth to ₹1 ...

May 15 (Reuters) - West Pharmaceutical Services said on Friday its operations were steadily recovering after a cyberattack earlier this month disrupted manufacturing and logistics globally. The ...

Bristol Myers Squibb and Hengrui Pharma signed a massive deal worth up to $15.2 billion. Takeda aims to cut 4,500 jobs in ...

Angelica Peebles, CNBC Health and Pharmaceutical Reporter, says U.S. drugmakers are accelerating China partnerships as ...

With the ink barely dry on outgoing commissioner Marty Makary’s resignation, another top regulator may be heading for the exit at the FDA.  | With the ink barely dry on outgoing commissioner Marty ...

Alembic Pharmaceuticals reported a 29% year-on-year rise in Q4 consolidated net profit to ₹202 crore, aided by 11% growth in ...

Mankind Pharma Ltd is quoting at Rs 2511.4, up 2% on the day as on 12:49 IST on the NSE. The stock is down 2.38% in last one year as compared to a 4.94% slide in NIFTY and a 13.93% slide in the Nifty ...

Meiji Seika Pharma Co., Ltd. (headquartered in Tokyo; President and Representative Director: Toshiaki Nagasato) today announced that the results of the Integral-1 study, one of two global Phase III ...

Indian drugmaker Alembic Pharmaceuticals posted a 29.2% rise in ​fourth-quarter profit on Friday, aided ‌by strong demand for its generic drugs and new launches in its ​key United States market.